These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Antimicrobial activity of cefodizime against clinical isolates]. Suzuki Y, Ishihara R, Ishii Y, Nakazawa A, Deguchi K, Matsumoto Y, Nishinari C, Nakane Y, Fukumoto T. Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558 [Abstract] [Full Text] [Related]
5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N. Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [Abstract] [Full Text] [Related]
8. [Antimicrobial activity of cefteram comparison with other oral antibiotics]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukushima Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Sato K. Jpn J Antibiot; 1989 May; 42(5):1216-32. PubMed ID: 2746861 [Abstract] [Full Text] [Related]
16. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. Forsgren A, Walder M. APMIS; 1994 Mar; 102(3):227-35. PubMed ID: 8185890 [Abstract] [Full Text] [Related]
17. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Tanimoto H, Nakata K, Nakamori Y, Nakatani T, Kusano N. Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [Abstract] [Full Text] [Related]
18. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. Nakamura T, Takahashi H. Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584 [Abstract] [Full Text] [Related]
19. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000]. Nakasone I, Onaga S, Fukunaga H, Saitoh H, Yamane N, Sato Y. Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533 [Abstract] [Full Text] [Related]